1. Home
  2. LEGN vs MAT Comparison

LEGN vs MAT Comparison

Compare LEGN & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • MAT
  • Stock Information
  • Founded
  • LEGN 2014
  • MAT 1945
  • Country
  • LEGN United States
  • MAT United States
  • Employees
  • LEGN N/A
  • MAT N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • MAT Recreational Games/Products/Toys
  • Sector
  • LEGN Health Care
  • MAT Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • MAT Nasdaq
  • Market Cap
  • LEGN 7.8B
  • MAT 6.6B
  • IPO Year
  • LEGN 2020
  • MAT N/A
  • Fundamental
  • Price
  • LEGN $34.68
  • MAT $18.66
  • Analyst Decision
  • LEGN Strong Buy
  • MAT Buy
  • Analyst Count
  • LEGN 13
  • MAT 8
  • Target Price
  • LEGN $81.54
  • MAT $23.75
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • MAT 3.8M
  • Earning Date
  • LEGN 11-12-2024
  • MAT 02-05-2025
  • Dividend Yield
  • LEGN N/A
  • MAT N/A
  • EPS Growth
  • LEGN N/A
  • MAT 570.79
  • EPS
  • LEGN N/A
  • MAT 1.57
  • Revenue
  • LEGN $520,183,000.00
  • MAT $5,353,829,000.00
  • Revenue This Year
  • LEGN $120.77
  • MAT N/A
  • Revenue Next Year
  • LEGN $68.54
  • MAT $3.06
  • P/E Ratio
  • LEGN N/A
  • MAT $11.83
  • Revenue Growth
  • LEGN 122.96
  • MAT 2.52
  • 52 Week Low
  • LEGN $32.66
  • MAT $15.87
  • 52 Week High
  • LEGN $70.13
  • MAT $20.60
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 32.71
  • MAT 44.35
  • Support Level
  • LEGN $40.97
  • MAT $18.70
  • Resistance Level
  • LEGN $43.96
  • MAT $19.37
  • Average True Range (ATR)
  • LEGN 2.03
  • MAT 0.48
  • MACD
  • LEGN -0.72
  • MAT -0.03
  • Stochastic Oscillator
  • LEGN 16.97
  • MAT 9.30

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About MAT Mattel Inc.

Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). More than 50% of its net sales are generated from North America, with the remainder stemming from international markets.

Share on Social Networks: